Narrow search
Showing 1 - 10 of 485,737
Cover Image
Competition in the pharmaceutical industry : the case of PAH drugs
Green, Kevin C. - In: International journal of the economics of business 16 (2009) 1, pp. 55-71
Persistent link: https://www.econbiz.de/10003825014
Cover Image
Do product innovation and news about the R&D process produce large price changes and overreaction? : the case of pharmaceutical stock prices
Pérez Rodríguez, Jorge V.; Valcarcel, Beatriz G. L. - In: Applied economics 44 (2012) 16/18, pp. 2217-2229
Persistent link: https://www.econbiz.de/10009572751
Cover Image
Pharmaceutical stock price reactions to price constraint threats and firm-level R&D spending
Golec, Joseph; Hedge, Shantaram; Henderson, J. Vernon - 2005
Persistent link: https://www.econbiz.de/10002717615
Cover Image
The economic consequences of US FDA new drug approvals : evidence from Taiwan pharmaceutical and biotech companies
Chen, Yong-Jie; Feng, Zhi-Yuan; Li, Yueh-Ping; Huang, … - In: Innovation: organization & management : IOM 23 (2021) 3, pp. 354-374
Persistent link: https://www.econbiz.de/10012649635
Cover Image
Risk dependence and cointegration between pharmaceutical stock markets : the case of China and the USA
Zhou, Xinmiao; Qian, Huanhuan; Pérez Rodríguez, Jorge V. - In: The North American journal of economics and finance : a … 52 (2020), pp. 1-19
Persistent link: https://www.econbiz.de/10012654918
Cover Image
The signaling effects of incremental information : evidence from stacked US Food and Drug Administration designations
Miller, Kathleen L.; Nardinelli, Clark; Pink, George H.; … - In: The quarterly review of economics and finance : journal … 67 (2018), pp. 219-226
Persistent link: https://www.econbiz.de/10012034461
Cover Image
The impact of the entry of biosimilars : evidence from Europe
Scott Morton, Fiona; Stern, Ariel D.; Stern, Scott - 2017
Persistent link: https://www.econbiz.de/10011708133
Cover Image
Evaluating the US pharmaceutical patent policy
Izhak, Olena; Saxell, Tanja; Takalo, Tuomas - 2021
The debate on whether COVID-19 vaccine patents are slowing down the pace of vaccination and the recovery from the crisis has brought the optimal design of pharmaceutical patent policy to the fore. In this paper we evaluate patent policy in the US pharmaceutical industry. We estimate the effect...
Persistent link: https://www.econbiz.de/10012802183
Cover Image
Market size in innovation : theory and evidence from the pharmaceutical industry
Acemoglu, Daron (contributor); Linn, Joshua (contributor) - 2003 - [Elektronische Ressource]
Persistent link: https://www.econbiz.de/10002115916
Cover Image
Modern pharmaceutical industry : a primer
Jacobsen, Thomas M. (contributor);  … - 2010
Persistent link: https://www.econbiz.de/10003821332